Jianfei Fu Department of Medical Oncology, Affiliated Jinhua Hospital Zhejiang University School of Medicine Biography Publications Institution JoVE Articles Jianfei Fu has not added a biography. If you are Jianfei Fu and would like to personalize this page please email our Author Liaison for assistance. Publications Inhibition of MAT2A-Related Methionine Metabolism Enhances The Efficacy of Cisplatin on Cisplatin-Resistant Cells in Lung Cancer Cell Journal. Apr, 2022 | Pubmed ID: 35674024 Specific Metabolic Response of Patient-derived Organoids to Curcumin of Colorectal Cancer Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. Jul, 2022 | Pubmed ID: 35598460 Metabolomics Studies on Cachexia in Patients with Cancer: a Scoping Review Protocol BMJ Open. 04, 2022 | Pubmed ID: 35414542 Estrogen Receptor-negative/progesterone Receptor-positive and Her-2-negative Breast Cancer Might No Longer Be Classified As Hormone Receptor-positive Breast Cancer International Journal of Clinical Oncology. Jul, 2022 | Pubmed ID: 35397755 Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer Clinical Breast Cancer. 04, 2022 | Pubmed ID: 34627728 The Role of Tumour Metabolism in Cisplatin Resistance Frontiers in Molecular Biosciences. 2021 | Pubmed ID: 34250022 Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer Frontiers in Cell and Developmental Biology. 2021 | Pubmed ID: 34055773 A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation OncoTargets and Therapy. 2021 | Pubmed ID: 33603403 Poorer Prognosis for Neuroendocrine Carcinoma Than Signet Ring Cell Cancer of the Colon and Rectum (CRC-NEC): a Propensity Score Matching Analysis of Patients from the Surveillance, Epidemiology, and End Results (SEER) Database International Journal of Colorectal Disease. Apr, 2021 | Pubmed ID: 33415449 The Effect of Adjuvant Treatment in Small Node-negative HER2-positive Breast Cancer: Which Subgroup Will Benefit? Clinical Breast Cancer. May, 2020 | Pubmed ID: 32653474 Early T Stage Is Associated With Poor Prognosis in Patients With Metastatic Liver Colorectal Cancer Frontiers in Oncology. 2020 | Pubmed ID: 32626650 P.L105Vfs Mutation in a Family with Thymic Neuroendocrine Tumor Combined with MEN1: a Case Report BMC Neurology. Mar, 2020 | Pubmed ID: 32126984 Identification of Core Genes and Pathways in Type 2 Diabetes Mellitus by Bioinformatics Analysis Molecular Medicine Reports. Sep, 2019 | Pubmed ID: 31524257 De-escalating Chemotherapy for Stage II Colon Cancer? Therapeutic Advances in Gastroenterology. 2019 | Pubmed ID: 31489031 Young-onset Breast Cancer: a Poor Prognosis Only Exists in Low-risk Patients Journal of Cancer. 2019 | Pubmed ID: 31289582 Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death Journal of Breast Cancer. Mar, 2019 | Pubmed ID: 30941237 Impact of Old Age on Resectable Colorectal Cancer Outcomes PeerJ. 2019 | Pubmed ID: 30792941 How Young Is Too Young in Breast Cancer?-Young Breast Cancer Is Not a Unique Biological Subtype Clinical Breast Cancer. 02, 2018 | Pubmed ID: 28802528 Real-world Impact of Non-breast Cancer-specific Death on Overall Survival in Resectable Breast Cancer Cancer. Jul, 2017 | Pubmed ID: 28267199 Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms Gastroenterology Research and Practice. 2017 | Pubmed ID: 28194176 Survival Outcomes and Surgical Intervention of Small Intestinal Neuroendocrine Tumors: a Population Based Retrospective Study Oncotarget. Jan, 2017 | Pubmed ID: 27903960 Signet Ring Cell Carcinoma of Resectable Metastatic Colorectal Cancer Has Rare Surgical Value Journal of Surgical Oncology. Dec, 2016 | Pubmed ID: 27891617 Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer PloS One. 2016 | Pubmed ID: 27760180 Hormone Receptor Status May Impact the Survival Benefit of Surgery in Stage Iv Breast Cancer: a Population-based Study Oncotarget. Oct, 2016 | Pubmed ID: 27542240 Synchronous Resectable Metastatic Colorectal Cancer: Lymph Node Involvement Predicts Poor Outcome Medicine. Jul, 2015 | Pubmed ID: 26222850 A Minor (<50%) Signet-ring Cell Component Associated with Poor Prognosis in Colorectal Cancer Patients: a 26-year Retrospective Study in China PloS One. 2015 | Pubmed ID: 25789685 Young Patients (≤ 35 Years Old) with Colorectal Cancer Have Worse Outcomes Due to More Advanced Disease: a 30-year Retrospective Review Medicine. Nov, 2014 | Pubmed ID: 25415667 为生存数据建立竞争风险回归 Nomogram 模型 Lunpo Wu1,2, Chenyang Ge3, Hongjuan Zheng4, Haiping Lin5, Wei Fu6, Jianfei Fu4 1Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, 2Institute of Gastroenterology, Zhejiang University, 3Department of Colorectal Surgery, Afiliated Jinhua Hospital, Zhejiang University School of Medicine, 4Department of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 5Department of Hepatobiliary Pancreatic Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 6Division of Oncology, Johns Hopkins University School of Medicine JoVE 60684 Cancer Research
为生存数据建立竞争风险回归 Nomogram 模型 Lunpo Wu1,2, Chenyang Ge3, Hongjuan Zheng4, Haiping Lin5, Wei Fu6, Jianfei Fu4 1Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, 2Institute of Gastroenterology, Zhejiang University, 3Department of Colorectal Surgery, Afiliated Jinhua Hospital, Zhejiang University School of Medicine, 4Department of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 5Department of Hepatobiliary Pancreatic Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 6Division of Oncology, Johns Hopkins University School of Medicine JoVE 60684 Cancer Research
